OUT

2
OUT IN rClaudin-4 136-209 C N OUT IN rClaudin-4 108-209 C N OUT IN N C rClaudin-2 136-230 OUT IN N C rClaudin-2 108-230 Claudin-2 OUT IN N C C OUT IN N Claudin-4 A Claudin-4 chimera second extracellular loop claudin- 4/E2 OUT I N Claudin-4 Claudin-2 OUT I N OUT I N Claudin-2 chimera second extracellular loop claudin- 2/E4 OUT I N N N N N C C C C B

description

OUT. OUT. OUT. OUT. IN. IN. N. N. C. C. rClaudin-2 136-230. rClaudin-4 136-209. IN. IN. N. N. C. C. Claudin-4. Claudin-2. OUT. OUT. OUT. OUT. IN. IN. N. N. C. C. rClaudin-2 108-230. rClaudin-4 108-209. IN. IN. N. N. C. C. - PowerPoint PPT Presentation

Transcript of OUT

Page 1: OUT

OUT

IN

rClaudin-4136-209

CN

OUT

IN

rClaudin-4108-209 C

N

OUT

INN C

rClaudin-2136-230

OUT

INN C

rClaudin-2108-230

Claudin-2

OUT

IN NCC

OUT

INN

Claudin-4

A

Claudin-4 chimera second

extracellular loop claudin-4/E2

OUT

IN

Claudin-4 Claudin-2

OUT

IN

OUT

IN

Claudin-2 chimera second

extracellular loop claudin-2/E4

OUT

IN NN

NN

CC

CC

B

Page 2: OUT

OUT

Claudin-4N149D N

C

OUT

IN NC

Claudin-1D150N

N

D

D

N

Claudin-2S149N

OUT

IN N

OUT

N

Claudin-4N149S

C C

S

N

N

S

C

Supplemental Fig. 1. Diagrams of claudins, chimeric claudins, claudin C-terminal fragments, and claudin mutants used in this study. (A) Predicted structure of the claudin components of recombinant claudin species used in Fig. 2 experiments. (B) Predicted structure of claudin chimera constructs used in Fig. 2 and 3, noting the change in the ECL-2 of Claudin-2/E4 and Claudin-4/E2. (C) Representation of claudin ECL-2 point mutations, with amino acid change indicated, that were used as soluble rClaudins in Fig. 5 experiments or were stably expressed by Rat1-R12 fibroblast transfectants in Fig. 6 studies.